Clinical Site Articles & Analysis
13 articles found
New Reimbursement for Technological Advancements The adoption of innovative medical technologies has become more accessible and feasible for clinical sites thanks to the growing support of reimbursement. This transformative shift signifies a pivotal change in the landscape of healthcare, clinical sites now benefit from improved ...
The QUEST study (High-FreQUEncy Nerve Block for PoST-Amputation Pain), is a randomized controlled study of 180 patients at 25 clinical study sites in the U.S. Recruitment for the study was completed in late 2021. ...
With the emergence of COVID-19, Decentralisation of Clinical Trials became necessary to comply with social distancing requirements while carrying out clinical research. Over the past few years, the clinical trial landscape has shifted its focus to patient-centric practices to promote patient engagement. But now as the pandemic is long gone, it is time to reflect on how DCT studies are genuinely ...
ByClinion
The Holiday season often brings mixed feelings for many. While it can be a time of relaxation with friends and family for some, for others, preparing for this time means ensuring business continuity despite a typical slow down. This can be a source of undue stress if it is not suitably planned for. ...
Revisiting the “why” behind decision making can be a helpful exercise in all aspects of business. This is no less true for clinical operations executives when it comes to the clinical trial systems they employ to facilitate their teams’ work. The technology that supports clinical trial systems has evolved steadily over the past several decades, yet the ultimate goal of ...
If you’re reading this, it’s likely that you’re in the market for a new prosthetic hand, and perhaps a bionic hand at that. In the age of technology, user reviews are a crucial component of the shopping process. After all, why try out a product if thousands of others have already deemed it insufficient? The same goes for prosthetic hands. Amputees want to hear from other users ...
When promising drug candidates are identified for further investigation in clinical trials, sponsor companies are usually optimistic about outcomes. But there are times, when after years of sunk effort and resources, clinical trials fail to bring a viable drug to market. Frequently, a drug fails for safety or efficacy reasons that are beyond a sponsor’s control. However, to some degree, ...
Pulmonary function testing is no longer solely the domain of specialized facilities or even hospitals. Clinics and individual practices now have the ability to perform the full range of testing directly at the point of care, saving time and improving efficiency. ...
The study, called USOPTIVAL, has been designed to collect blood samples and clinical data from 1,100 subjects, aged 45-84, who have a suspected advanced adenoma or have newly diagnosed with CRC scheduled for resection surgery. ...
With Regeneron’s high profile, single-person, single-site, clinical trial proving successful (along with much supporting other clinical ...
Myles Greenberg describes this exciting new technology and the path to patients, with first-in-human clinical trials launching earlier this year. What is the story behind the technology? ...
Origin, Inc., a Phase III clinical-stage biotechnology company, today announced that it had applied to NMPA (formerly CFDA) for classification of its plasma-generated nitric oxide device for the purposes of conducting clinical trials in Hong Kong and mainland China, and that NMPA had accepted its submission. ...
The latest evolution is single incision laparoscopic cholecystectomy (SILC). Single-site robotic cholecystectomy (SSRC) overcomes several limitations of manual SILC. The aim of this study is to present our initial experiences in SSRC and to compare its clinical outcomes with those of SILC. Methods: This study retrospectively reviewed data for patients who ...